Caitlin Cronin
Stock Analyst at Canaccord Genuity
(4.74)
# 163
Out of 4,761 analysts
20
Total ratings
73.33%
Success rate
28.72%
Average return
Main Sectors:
Stocks Rated by Caitlin Cronin
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
VCEL Vericel | Maintains: Buy | $64 → $67 | $52.00 | +28.85% | 3 | Feb 3, 2025 | |
AXGN Axogen | Maintains: Buy | $18 → $22 | $18.00 | +22.22% | 3 | Feb 3, 2025 | |
KRMD KORU Medical Systems | Maintains: Buy | $3 → $4 | $3.71 | +7.82% | 2 | Nov 14, 2024 | |
TELA TELA Bio | Maintains: Buy | $12 | $2.72 | +341.18% | 3 | Oct 4, 2024 | |
ATEC Alphatec Holdings | Maintains: Buy | $20 | $10.61 | +88.50% | 3 | Aug 30, 2024 | |
INMD InMode | Maintains: Hold | $21 → $16 | $18.90 | -15.34% | 2 | Jul 12, 2024 | |
ZBH Zimmer Biomet Holdings | Reiterates: Hold | $130 | $104.83 | +24.01% | 1 | Feb 23, 2024 | |
ENOV Enovis | Maintains: Buy | $73 → $75 | $42.71 | +75.60% | 1 | Feb 23, 2024 | |
GMED Globus Medical | Reiterates: Buy | $79 | $80.28 | -1.59% | 1 | Feb 21, 2024 | |
RBOT Vicarious Surgical | Downgrades: Hold | $270 → $12 | $14.38 | -16.55% | 1 | Nov 14, 2023 |
Vericel
Feb 3, 2025
Maintains: Buy
Price Target: $64 → $67
Current: $52.00
Upside: +28.85%
Axogen
Feb 3, 2025
Maintains: Buy
Price Target: $18 → $22
Current: $18.00
Upside: +22.22%
KORU Medical Systems
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $3.71
Upside: +7.82%
TELA Bio
Oct 4, 2024
Maintains: Buy
Price Target: $12
Current: $2.72
Upside: +341.18%
Alphatec Holdings
Aug 30, 2024
Maintains: Buy
Price Target: $20
Current: $10.61
Upside: +88.50%
InMode
Jul 12, 2024
Maintains: Hold
Price Target: $21 → $16
Current: $18.90
Upside: -15.34%
Zimmer Biomet Holdings
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $104.83
Upside: +24.01%
Enovis
Feb 23, 2024
Maintains: Buy
Price Target: $73 → $75
Current: $42.71
Upside: +75.60%
Globus Medical
Feb 21, 2024
Reiterates: Buy
Price Target: $79
Current: $80.28
Upside: -1.59%
Vicarious Surgical
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $14.38
Upside: -16.55%